BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 32938851)

  • 1. Chronotherapy with a Renin-angiotensin System Inhibitor Ameliorates Renal Damage by Suppressing Intrarenal Renin-angiotensin System Activation.
    Aoki T; Ohashi N; Isobe S; Ishigaki S; Matsuyama T; Sato T; Fujikura T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2020; 59(18):2237-2244. PubMed ID: 32938851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease.
    Ishigaki S; Ohashi N; Isobe S; Tsuji N; Iwakura T; Ono M; Sakao Y; Tsuji T; Kato A; Miyajima H; Yasuda H
    Clin Exp Nephrol; 2016 Dec; 20(6):878-884. PubMed ID: 26743744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules.
    Ohashi N; Aoki T; Matsuyama T; Ishigaki S; Isobe S; Katahashi N; Sato T; Fujikura T; Kato A; Yasuda H
    Intern Med; 2020 Feb; 59(3):357-364. PubMed ID: 31534091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Relationship between the Intrarenal Dopamine System and Intrarenal Renin-angiotensin System Depending on the Renal Function.
    Matsuyama T; Ohashi N; Ishigaki S; Isobe S; Tsuji N; Fujikura T; Tsuji T; Kato A; Miyajima H; Yasuda H
    Intern Med; 2018 Nov; 57(22):3241-3247. PubMed ID: 29984779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Intrarenal Renin-angiotensin System Is Activated Immediately after Kidney Donation in Kidney Transplant Donors.
    Ohashi N; Isobe S; Matsuyama T; Ishigaki S; Suzuki T; Tsuji T; Otsuka A; Kato A; Miyake H; Yasuda H
    Intern Med; 2019 Mar; 58(5):643-648. PubMed ID: 30333423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperuricaemia is associated with renal damage independently of hypertension and intrarenal renin-angiotensin system activation, as well as their circadian rhythms.
    Ohashi N; Ishigaki S; Isobe S; Tsuji N; Iwakura T; Ono M; Tsuji T; Sakao Y; Kato A; Yasuda H
    Nephrology (Carlton); 2015 Nov; 20(11):814-9. PubMed ID: 25968901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disturbed circadian rhythm of the intrarenal renin-angiotensin system: relevant to nocturnal hypertension and renal damage.
    Isobe S; Ohashi N; Fujikura T; Tsuji T; Sakao Y; Yasuda H; Kato A; Miyajima H; Fujigaki Y
    Clin Exp Nephrol; 2015 Apr; 19(2):231-9. PubMed ID: 24728489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELISA examining urinary angiotensinogen as a potential indicator of intrarenal renin-angiotensin system (RAS) activity: a clinical study of 128 chronic kidney disease patients.
    Zhang XY; Ding XQ; Lv WL; Teng J; Zhong YH
    Mol Biol Rep; 2013 Oct; 40(10):5817-24. PubMed ID: 24065527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased heart rate is associated with intrarenal renin-angiotensin system activation in chronic kidney disease patients.
    Ohashi N; Isobe S; Ishigaki S; Aoki T; Matsuyama T; Sato T; Fujikura T; Kato A; Yasuda H
    Clin Exp Nephrol; 2019 Sep; 23(9):1109-1118. PubMed ID: 31131423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Night-time activation of the intrarenal renin-angiotensin system due to nocturnal hypertension is associated with renal arteriosclerosis in normotensive IgA nephropathy patients.
    Ohashi N; Isobe S; Matsuyama T; Ishigaki S; Tsuji N; Fujikura T; Tsuji T; Kato A; Yasuda H
    Hypertens Res; 2018 May; 41(5):334-341. PubMed ID: 29507351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients.
    Kobori H; Alper AB; Shenava R; Katsurada A; Saito T; Ohashi N; Urushihara M; Miyata K; Satou R; Hamm LL; Navar LG
    Hypertension; 2009 Feb; 53(2):344-50. PubMed ID: 19075095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary angiotensinogen as a potential biomarker of intrarenal renin-angiotensin system activity in Chinese chronic kidney disease patients.
    Xu Z; Xu B; Xu C
    Ir J Med Sci; 2015 Jun; 184(2):297-304. PubMed ID: 24664631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Urinary Angiotensinogen Excretion Predicts Deterioration of the Kidney Function in Patients with Chronic Kidney Disease.
    Ishigaki S; Ohashi N; Aoki T; Matsuyama T; Isobe S; Sato T; Fujikura T; Kato A; Yasuda H
    Intern Med; 2021 Jul; 60(14):2201-2206. PubMed ID: 33612680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in urinary angiotensinogen levels and improvement of proteinuria by renin-angiotensin system blockade in pediatric chronic kidney disease patients with very low birth weight.
    Yamamura-Miyazaki N; Michigami T; Satomura K; Urushihara M; Kagami S; Yamamoto K
    Pediatr Nephrol; 2020 Jul; 35(7):1307-1314. PubMed ID: 32162100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor glycemic control and decreased renal function are associated with increased intrarenal RAS activity in Type 2 diabetes mellitus.
    Nakatani S; Ishimura E; Naganuma T; Nakatani A; Ichii M; Fukumoto S; Mori K; Emoto M; Nakatani T; Inaba M
    Diabetes Res Clin Pract; 2014 Jul; 105(1):40-6. PubMed ID: 24846444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary Angiotensinogen in addition to Imaging Classification in the Prediction of Renal Outcome in Autosomal Dominant Polycystic Kidney Disease.
    Park HC; Kim J; Cho A; Kim DH; Lee YK; Ryu H; Kim H; Oh KH; Oh YK; Hwang YH; Lee KB; Kim SW; Kim YH; Lee J; Ahn C;
    J Korean Med Sci; 2020 Jun; 35(22):e165. PubMed ID: 32508065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian rhythm of blood pressure and the renin-angiotensin system in the kidney.
    Ohashi N; Isobe S; Ishigaki S; Yasuda H
    Hypertens Res; 2017 May; 40(5):413-422. PubMed ID: 27904154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pivotal role of melatonin in ameliorating chronic kidney disease by suppression of the renin-angiotensin system in the kidney.
    Ohashi N; Ishigaki S; Isobe S
    Hypertens Res; 2019 Jun; 42(6):761-768. PubMed ID: 30610209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in Urinary Angiotensinogen Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes Mellitus.
    Lee MJ; Kim SS; Kim IJ; Song SH; Kim EH; Seo JY; Kim JH; Kim S; Jeon YK; Kim BH; Kim YK
    J Korean Med Sci; 2017 May; 32(5):782-788. PubMed ID: 28378551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease.
    Mills KT; Kobori H; Hamm LL; Alper AB; Khan IE; Rahman M; Navar LG; Liu Y; Browne GM; Batuman V; He J; Chen J
    Nephrol Dial Transplant; 2012 Aug; 27(8):3176-81. PubMed ID: 22399491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.